Natixis Novo Nordisk A S Transaction History

Natixis

$17.6 Billion
Q3 2024

A detailed history of Natixis transactions in Novo Nordisk A S stock. As of the latest transaction made, Natixis holds 2,606 shares of NVO stock, worth $269,564. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,606

Previous 186 1301.08%

Holding current value

$269,564

Previous $26,000 1092.31%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$119.07 - $145.42 $288,149 - $351,916	2,420 Added 1301.08%	2,606 $310,000
Q2 2024 Aug 13, 2024	SELL	$122.71 - $146.91 $701,533 - $839,884	-5,717 Reduced 96.85%	186 $26,000
Q1 2024 May 13, 2024	BUY	$102.11 - $135.92 $531,686 - $707,735	5,207 Added 748.13%	5,903 $757,000
Q4 2023 Feb 13, 2024	SELL	$87.78 - $105.45 $70,487 - $84,676	-803 Reduced 53.57%	696 $72,000
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $136,319 - $299,110	1,499 New	1,499 $136,000
Q2 2022 Aug 12, 2022	SELL	$103.24 - $121.81 $196,052 - $231,317	-1,899 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $4,189 - $5,064	45 Added 2.43%	1,899 $211,000
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $177,761 - $217,066	1,854 New	1,854 $208,000
Q2 2019 Aug 13, 2019	SELL	$46.79 - $52.47 $564,755 - $633,312	-12,070 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $118,032 - $133,995	2,546 Added 26.73%	12,070 $628,000
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $8,224 - $9,355	-198 Reduced 2.04%	9,524 $439,000
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $129,197 - $141,576	2,763 Added 39.7%	9,722 $458,000
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $117,944 - $134,268	2,663 Added 61.99%	6,959 $321,000
Q1 2018 May 15, 2018	BUY	$48.49 - $58.14 $11,540 - $13,837	238 Added 5.86%	4,296 $212,000
Q4 2017 Feb 14, 2018	BUY	$47.53 - $53.73 $192,876 - $218,036	4,058 New	4,058 $218,000
Q3 2017 Nov 14, 2017	SELL	$41.15 - $49.22 $379,197 - $453,562	-9,215 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	9,215	9,215 $395,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $233B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account